Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Drug Delivery with Extracellular Vesicles: From Imagination to Innovation.

de Jong OG, Kooijmans SAA, Murphy DE, Jiang L, Evers MJW, Sluijter JPG, Vader P, Schiffelers RM.

Acc Chem Res. 2019 Jun 5. doi: 10.1021/acs.accounts.9b00109. [Epub ahead of print]

PMID:
31181910
2.

Interfering with endolysosomal trafficking enhances release of bioactive exosomes.

Ortega FG, Roefs MT, de Miguel Perez D, Kooijmans SA, de Jong OG, Sluijter JP, Schiffelers RM, Vader P.

Nanomedicine. 2019 May 30:102014. doi: 10.1016/j.nano.2019.102014. [Epub ahead of print]

3.

Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis.

Bracco Gartner TCL, Deddens JC, Mol EA, Magin Ferrer M, van Laake LW, Bouten CVC, Khademhosseini A, Doevendans PA, Suyker WJL, Sluijter JPG, Hjortnaes J.

Front Cardiovasc Med. 2019 Apr 26;6:52. doi: 10.3389/fcvm.2019.00052. eCollection 2019.

4.

Follistatin-like 1 in Cardiovascular Disease and Inflammation.

Peters MMC, Meijs TA, Gathier W, Doevendans PAM, Sluijter JPG, Chamuleau SAJ, Neef K.

Mini Rev Med Chem. 2019 Mar 12. doi: 10.2174/1389557519666190312161551. [Epub ahead of print]

PMID:
30864520
5.

Circadian rhythms and the molecular clock in cardiovascular biology and disease.

Crnko S, Du Pré BC, Sluijter JPG, Van Laake LW.

Nat Rev Cardiol. 2019 Jul;16(7):437-447. doi: 10.1038/s41569-019-0167-4. Review.

PMID:
30796369
6.

Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.

Bei Y, Pan LL, Zhou Q, Zhao C, Xie Y, Wu C, Meng X, Gu H, Xu J, Zhou L, Sluijter JPG, Das S, Agerberth B, Sun J, Xiao J.

BMC Med. 2019 Feb 20;17(1):42. doi: 10.1186/s12916-019-1268-y.

7.

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.

de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschöpe C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C, Heymans S.

Eur J Heart Fail. 2019 Mar;21(3):272-285. doi: 10.1002/ejhf.1406. Epub 2019 Feb 4.

8.

ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.

Cardiovasc Res. 2019 Mar 1;115(3):488-500. doi: 10.1093/cvr/cvz010.

PMID:
30657875
9.

Cardiomyocyte Progenitor Cells as a Functional Gene Delivery Vehicle for Long-Term Biological Pacing.

Végh AMD, den Haan AD, Cócera Ortega L, Verkerk AO, Sluijter JPG, Bakker D, van Amersfoorth S, van Veen TAB, Klerk M, Seppen J, de Bakker JMT, Christoffels VM, Geerts D, Goumans MJTH, Tan HL, Boink GJJ.

Molecules. 2019 Jan 5;24(1). pii: E181. doi: 10.3390/molecules24010181.

10.

Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.

Maring JA, Lodder K, Mol E, Verhage V, Wiesmeijer KC, Dingenouts CKE, Moerkamp AT, Deddens JC, Vader P, Smits AM, Sluijter JPG, Goumans MJ.

J Cardiovasc Transl Res. 2019 Feb;12(1):5-17. doi: 10.1007/s12265-018-9842-9. Epub 2018 Nov 19.

11.

Circular RNAs as Potential Theranostics in the Cardiovascular System.

Bei Y, Yang T, Wang L, Holvoet P, Das S, Sluijter JPG, Monteiro MC, Liu Y, Zhou Q, Xiao J.

Mol Ther Nucleic Acids. 2018 Dec 7;13:407-418. doi: 10.1016/j.omtn.2018.09.022. Epub 2018 Oct 2. Review.

12.

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

van Mil A, Balk GM, Neef K, Buikema JW, Asselbergs FW, Wu SM, Doevendans PA, Sluijter JPG.

Cardiovasc Res. 2018 Dec 1;114(14):1828-1842. doi: 10.1093/cvr/cvy208.

PMID:
30169602
13.

Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles.

van den Akker F, Vrijsen KR, Deddens JC, Buikema JW, Mokry M, van Laake LW, Doevendans PA, Sluijter JPG.

Heliyon. 2018 Jun 6;4(6):e00642. doi: 10.1016/j.heliyon.2018.e00642. eCollection 2018 Jun.

14.

MMISH: Multicolor microRNA in situ hybridization for paraffin embedded samples.

Lei Z, van Mil A, Xiao J, Metz CHG, van Eeuwijk ECM, Doevendans PA, Sluijter JPG.

Biotechnol Rep (Amst). 2018 May 1;18:e00255. doi: 10.1016/j.btre.2018.e00255. eCollection 2018 Jun.

15.

Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review.

Gohar A, de Kleijn DPV, Hoes AW, Rutten FH, Hilfiker-Kleiner D, Ferdinandy P, Sluijter JPG, den Ruijter HM.

Vascul Pharmacol. 2018 Dec;111:1-6. doi: 10.1016/j.vph.2018.05.006. Epub 2018 May 26. Review.

PMID:
29807165
16.

Engineering a 3D-Bioprinted Model of Human Heart Valve Disease Using Nanoindentation-Based Biomechanics.

van der Valk DC, van der Ven CFT, Blaser MC, Grolman JM, Wu PJ, Fenton OS, Lee LH, Tibbitt MW, Andresen JL, Wen JR, Ha AH, Buffolo F, van Mil A, Bouten CVC, Body SC, Mooney DJ, Sluijter JPG, Aikawa M, Hjortnaes J, Langer R, Aikawa E.

Nanomaterials (Basel). 2018 May 3;8(5). pii: E296. doi: 10.3390/nano8050296.

17.

Publisher Correction: Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies.

Zwetsloot PP, Kouwenberg LHJA, Sena ES, Eding JE, den Ruijter HM, Sluijter JPG, Pasterkamp G, Doevendans PA, Hoefer IE, Chamuleau SAJ, van Hout GPJ, Jansen Of Lorkeers SJ.

Sci Rep. 2018 Apr 11;8(1):6047. doi: 10.1038/s41598-018-23615-9.

18.

Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems.

Wu H, Liu Q, Shi H, Xie J, Zhang Q, Ouyang Z, Li N, Yang Y, Liu Z, Zhao Y, Lai C, Ruan D, Peng J, Ge W, Chen F, Fan N, Jin Q, Liang Y, Lan T, Yang X, Wang X, Lei Z, Doevendans PA, Sluijter JPG, Wang K, Li X, Lai L.

Cell Mol Life Sci. 2018 Oct;75(19):3593-3607. doi: 10.1007/s00018-018-2810-3. Epub 2018 Apr 10.

PMID:
29637228
19.

Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice.

de Haan JJ, Bosch L, Borgman A, Bastemeijer M, Brans MAD, van de Weg SM, de Kleijn DPV, Sluijter JPG, El Azzouzi H, de Jager SCA.

Sci Rep. 2017 Dec 6;7(1):17045. doi: 10.1038/s41598-017-16957-3.

20.

Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing.

Wang K, Jin Q, Ruan D, Yang Y, Liu Q, Wu H, Zhou Z, Ouyang Z, Liu Z, Zhao Y, Zhao B, Zhang Q, Peng J, Lai C, Fan N, Liang Y, Lan T, Li N, Wang X, Wang X, Fan Y, Doevendans PA, Sluijter JPG, Liu P, Li X, Lai L.

Genome Res. 2017 Dec;27(12):2061-2071. doi: 10.1101/gr.222521.117. Epub 2017 Nov 16.

21.

Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.

Sluijter JPG, Davidson SM, Boulanger CM, Buzás EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P.

Cardiovasc Res. 2018 Jan 1;114(1):19-34. doi: 10.1093/cvr/cvx211. Review.

22.

Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies.

Zwetsloot PP, Kouwenberg LHJA, Sena ES, Eding JE, den Ruijter HM, Sluijter JPG, Pasterkamp G, Doevendans PA, Hoefer IE, Chamuleau SAJ, van Hout GPJ, Jansen Of Lorkeers SJ.

Sci Rep. 2017 Oct 27;7(1):14218. doi: 10.1038/s41598-017-14294-z. Erratum in: Sci Rep. 2018 Apr 11;8(1):6047.

23.

miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1.

Xiao J, Liu H, Cretoiu D, Toader DO, Suciu N, Shi J, Shen S, Bei Y, Sluijter JP, Das S, Kong X, Li X.

Exp Mol Med. 2017 Oct 20;49(10):e386. doi: 10.1038/emm.2017.150.

24.

Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair.

Mol EA, Goumans MJ, Sluijter JPG.

Adv Exp Med Biol. 2017;998:207-219. doi: 10.1007/978-981-10-4397-0_14. Review.

PMID:
28936742
25.

Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply.

Hausenloy DJ, Garcia-Dorado D, Erik Bøtker H, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P.

Cardiovasc Res. 2017 Sep 1;113(11):1418-1419. doi: 10.1093/cvr/cvx137. No abstract available.

PMID:
28859295
26.

ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.

Thielmann M, Sharma V, Al-Attar N, Bulluck H, Bisleri G, Bunge JJH, Czerny M, Ferdinandy P, Frey UH, Heusch G, Holfeld J, Kleinbongard P, Kunst G, Lang I, Lentini S, Madonna R, Meybohm P, Muneretto C, Obadia JF, Perrino C, Prunier F, Sluijter JPG, Van Laake LW, Sousa-Uva M, Hausenloy DJ.

Eur Heart J. 2017 Aug 14;38(31):2392-2407. doi: 10.1093/eurheartj/ehx383. No abstract available.

27.

SCA1+ Cells from the Heart Possess a Molecular Circadian Clock and Display Circadian Oscillations in Cellular Functions.

Du Pré BC, Demkes EJ, Feyen DAM, Dierickx P, Crnko S, Kok BJM, Sluijter JPG, Doevendans PA, Vos MA, Van Veen TAB, Van Laake LW.

Stem Cell Reports. 2017 Sep 12;9(3):762-769. doi: 10.1016/j.stemcr.2017.07.010. Epub 2017 Aug 10.

28.

Melt Electrospinning Writing of Poly-Hydroxymethylglycolide-co-ε-Caprolactone-Based Scaffolds for Cardiac Tissue Engineering.

Castilho M, Feyen D, Flandes-Iparraguirre M, Hochleitner G, Groll J, Doevendans PAF, Vermonden T, Ito K, Sluijter JPG, Malda J.

Adv Healthc Mater. 2017 Sep;6(18). doi: 10.1002/adhm.201700311. Epub 2017 Jul 12.

PMID:
28699224
29.

Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.

Sadeghi AH, Shin SR, Deddens JC, Fratta G, Mandla S, Yazdi IK, Prakash G, Antona S, Demarchi D, Buijsrogge MP, Sluijter JPG, Hjortnaes J, Khademhosseini A.

Adv Healthc Mater. 2017 Jun;6(11). doi: 10.1002/adhm.201601434. Epub 2017 May 12.

30.

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Perrino C, Barabási AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JPG, Schulz R, Thum T, Ytrehus K, Ferdinandy P.

Cardiovasc Res. 2017 Jun 1;113(7):725-736. doi: 10.1093/cvr/cvx070. Review.

31.

Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Hausenloy DJ, Garcia-Dorado D, Bøtker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P.

Cardiovasc Res. 2017 May 1;113(6):564-585. doi: 10.1093/cvr/cvx049. Review.

PMID:
28453734
32.

Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation.

Mol EA, Goumans MJ, Doevendans PA, Sluijter JPG, Vader P.

Nanomedicine. 2017 Aug;13(6):2061-2065. doi: 10.1016/j.nano.2017.03.011. Epub 2017 Mar 30.

33.

Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.

Deddens JC, Feyen DA, Zwetsloot PP, Brans MA, Siddiqi S, van Laake LW, Doevendans PA, Sluijter JP.

PLoS One. 2017 Mar 20;12(3):e0173657. doi: 10.1371/journal.pone.0173657. eCollection 2017.

34.

miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.

Shi J, Bei Y, Kong X, Liu X, Lei Z, Xu T, Wang H, Xuan Q, Chen P, Xu J, Che L, Liu H, Zhong J, Sluijter JP, Li X, Rosenzweig A, Xiao J.

Theranostics. 2017 Jan 15;7(3):664-676. doi: 10.7150/thno.15162. eCollection 2017.

35.

Cardiac-released extracellular vesicles can activate endothelial cells.

Deddens JC, Vrijsen KR, Girao H, Doevendans PA, Sluijter JP.

Ann Transl Med. 2017 Feb;5(3):64. doi: 10.21037/atm.2017.01.75. No abstract available.

36.

Intramyocardial stem cell injection: go(ne) with the flow.

van den Akker F, Feyen DA, van den Hoogen P, van Laake LW, van Eeuwijk EC, Hoefer I, Pasterkamp G, Chamuleau SA, Grundeman PF, Doevendans PA, Sluijter JP.

Eur Heart J. 2017 Jan 14;38(3):184-186. doi: 10.1093/eurheartj/ehw056. No abstract available.

PMID:
28158468
37.

In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.

van der Ven CF, Wu PJ, Tibbitt MW, van Mil A, Sluijter JP, Langer R, Aikawa E.

Clin Sci (Lond). 2017 Feb 1;131(3):181-195. doi: 10.1042/CS20160378. Review.

38.

MicroRNAs: The Swing Voters in Vascular Disease Waiting for a Program.

Sluijter JP, Pasterkamp G.

Circ Res. 2017 Jan 6;120(1):5-7. doi: 10.1161/CIRCRESAHA.116.310215. No abstract available.

PMID:
28057779
39.

Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.

Deddens JC, Sadeghi AH, Hjortnaes J, van Laake LW, Buijsrogge M, Doevendans PA, Khademhosseini A, Sluijter JP.

Adv Healthc Mater. 2017 Feb;6(3). doi: 10.1002/adhm.201600571. Epub 2016 Dec 1. Review.

PMID:
27906521
40.

Stem cell-based therapy: Improving myocardial cell delivery.

Feyen DAM, Gaetani R, Doevendans PA, Sluijter JPG.

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):104-115. doi: 10.1016/j.addr.2016.04.023. Epub 2016 Apr 29. Review.

PMID:
27133386
41.

Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin.

Martins-Marques T, Pinho MJ, Zuzarte M, Oliveira C, Pereira P, Sluijter JP, Gomes C, Girao H.

J Extracell Vesicles. 2016 Sep 29;5:32538. doi: 10.3402/jev.v5.32538. eCollection 2016.

42.

Crucial Role of miR-433 in Regulating Cardiac Fibrosis.

Tao L, Bei Y, Chen P, Lei Z, Fu S, Zhang H, Xu J, Che L, Chen X, Sluijter JP, Das S, Cretoiu D, Xu B, Zhong J, Xiao J, Li X.

Theranostics. 2016 Sep 10;6(12):2068-2083. eCollection 2016.

43.

Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.

Vrijsen KR, Maring JA, Chamuleau SA, Verhage V, Mol EA, Deddens JC, Metz CH, Lodder K, van Eeuwijk EC, van Dommelen SM, Doevendans PA, Smits AM, Goumans MJ, Sluijter JP.

Adv Healthc Mater. 2016 Oct;5(19):2555-2565. doi: 10.1002/adhm.201600308. Epub 2016 Aug 29.

PMID:
27570124
44.

Responder Definition in Clinical Stem Cell Trials in Cardiology: Will the Real Responder Please Stand Up?

Zwetsloot PP, Gremmels H, Assmus B, Koudstaal S, Sluijter JP, Zeiher AM, Chamuleau SA.

Circ Res. 2016 Aug 5;119(4):514-8. doi: 10.1161/CIRCRESAHA.116.308733. Review. No abstract available.

PMID:
27492842
45.

Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury.

Deddens JC, Vrijsen KR, Colijn JM, Oerlemans MI, Metz CH, van der Vlist EJ, Nolte-'t Hoen EN, den Ouden K, Jansen Of Lorkeers SJ, van der Spoel TI, Koudstaal S, Arkesteijn GJ, Wauben MH, van Laake LW, Doevendans PA, Chamuleau SA, Sluijter JP.

J Cardiovasc Transl Res. 2016 Aug;9(4):291-301. doi: 10.1007/s12265-016-9705-1. Epub 2016 Jul 6.

46.

Long non-coding RNAs in heart failure: an obvious lnc.

El Azzouzi H, Doevendans PA, Sluijter JP.

Ann Transl Med. 2016 May;4(9):182. doi: 10.21037/atm.2016.05.06.

47.

Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells.

Feyen DA, van den Akker F, Noort W, Chamuleau SA, Doevendans PA, Sluijter JP.

Methods Mol Biol. 2016;1416:225-32. doi: 10.1007/978-1-4939-3584-0_12.

PMID:
27236674
48.

Sepsis-associated cardiac dysfunction is controlled by small RNA molecules.

Sluijter JP, Doevendans PA.

J Mol Cell Cardiol. 2016 Aug;97:67-9. doi: 10.1016/j.yjmcc.2016.05.005. Epub 2016 May 10. No abstract available.

PMID:
27178728
49.

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.

Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, Leor J, Perrino C, Schulz R, Ytrehus K, Landmesser U, Mummery CL, Janssens S, Willerson J, Eschenhagen T, Ferdinandy P, Sluijter JP.

Eur Heart J. 2016 Jun 14;37(23):1789-98. doi: 10.1093/eurheartj/ehw113. Epub 2016 Apr 7. Review.

50.

Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium.

Feyen DA, Gaetani R, Deddens J, van Keulen D, van Opbergen C, Poldervaart M, Alblas J, Chamuleau S, van Laake LW, Doevendans PA, Sluijter JP.

Adv Healthc Mater. 2016 May;5(9):1071-9. doi: 10.1002/adhm.201500861. Epub 2016 Feb 23.

PMID:
26913710

Supplemental Content

Loading ...
Support Center